Mico BioMed Selected as Finalist for 'AI Voucher Project' with In Vitro Diagnostic Customer Service Chatbot

[Asia Economy Reporter Lee Gwan-ju] MikobioMed, a manufacturer of in vitro diagnostic medical devices, announced on the 10th that it has been finally selected for the 2022 AI Voucher Support Project hosted by the National IT Industry Promotion Agency (NIPA).

The AI Voucher Support Project is a program by NIPA under the Ministry of Science and ICT that promotes digital transformation and supports the use of artificial intelligence for small and venture companies challenging innovation.

MikobioMed plans to develop an AI chatbot for customer service in the field of in vitro diagnostics. Through the chatbot, product usage instructions, purchase inquiries, and AS requests will be handled 24 hours a day.

A company official explained, "Due to the rapid spread of the Omicron variant recently, the number of domestic and international users of our COVID-19 diagnostic kits has sharply increased," adding, "We aim to digitize customer inquiries about our diagnostic equipment, kits, and diagnostic systems (applications) and provide convenience to customers worldwide through AI solutions."

Furthermore, by offering services in English and local languages of major export countries (Malay, Vietnamese, Indonesian, Spanish, etc.), the company plans to strengthen its brand image by securing customers and improving consumer satisfaction. MikobioMed plans to complete and apply this project by October this year.

This content was produced with the assistance of AI translation services.